Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Randomized Double Blind Trial Of Megestrol Acetate Versus Placebo For The Treatment Of Inoperable Hepatocellular Carcinoma
Sponsor: National Medical Research Council (NMRC), Singapore
A PHASE3 clinical study on Liver Cancer, this trial is completed. The trial is conducted by National Medical Research Council (NMRC), Singapore and has accumulated 6 data snapshots since 2002. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
May 2002
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Medical Research Council (NMRC), Singapore
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Auckland, New Zealand, Bangkok, Thailand, Davao City, Philippines, Denpasar, Indonesia, Dhaka, Bangladesh, Ho Chi Minh City, Vietnam, Hà Nội, Vietnam, Singapore, Singapore, Suwon, South Korea, Taipei, Taiwan and 1 more location